Publicacións en colaboración con investigadores/as de University of Rome Tor Vergata (9)

2018

  1. Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and breast/ovarian) cancer susceptibility genes: An international survey by the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) clinical working group

    JCO Precision Oncology, Vol. 2

2017

  1. Correction: A european spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics (PLoS ONE (2016) 11:9 (e0162866) DOI: 10.1371/journal.pone.0162866)

    PLoS ONE

  2. Making progress in educationThe EUROFORGEN master degree pilot project in forensic genetics

    Forensic Science International: Genetics

2016

  1. A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics

    PLoS ONE, Vol. 11, Núm. 9

2014

  1. Common variant at 16p11.2 conferring risk of psychosis

    Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114

  2. The molecular characterization of a depurinated trial DNA sample can be a model to understand the reliability of the results in forensic genetics

    Electrophoresis, Vol. 35, Núm. 21-22, pp. 3134-3144

2011

  1. Common variants at VRK2 and TCF4 conferring risk of schizophrenia

    Human Molecular Genetics, Vol. 20, Núm. 20, pp. 4076-4081

  2. Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: A study in Spanish and Italian populations and meta-analysis

    Arthritis and Rheumatism, Vol. 63, Núm. 7, pp. 1860-1865

2004

  1. Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial

    Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092